Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noah Federman

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
The Lancet. Oncology|April 3, 2018
Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 studyTheodore W Laetsch, Steven G DuBois, Leo Mascarenhas, et al.
JCO Precision Oncology|January 8, 2019
Clinical Factors That Affect the Establishment of Soft Tissue Sarcoma Patient-Derived Orthotopic Xenografts: A University of California, Los Angeles, Sarcoma Program Prospective Clinical TrialTara A Russell, Mark A Eckardt, Takashi Murakami, et al.
American Journal of Clinical Oncology|April 18, 2018
Long-term Outcomes With Ifosfamide-based Hypofractionated Preoperative Chemoradiotherapy for Extremity Soft Tissue SarcomasJoseph Daniel Pennington, Fritz C Eilber, Frederick R Eilber, et al.
Oncotarget|June 11, 2016
Effective molecular targeting of CDK4/6 and IGF-1R in a rare FUS-ERG fusion CDKN2A-deletion doxorubicin-resistant Ewing's sarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse modelTakashi Murakami, Arun S Singh, Tasuku Kiyuna, et al.
Advanced Functional Materials|July 5, 2021
Coupling Nanostructured Microchips with Covalent Chemistry Enables Purification of Sarcoma-Derived Extracellular Vesicles for Downstream Functional StudiesJiantong Dong, Ryan Y Zhang, Na Sun, et al.
Surgery|October 10, 2025
Dedicated review of sarcoma pathology is necessary for corroborative diagnosis in nearly one half of referred patientsMark A Eckardt, Nicholas M Siena, Amy R Copeland, et al.
Sarcoma|May 14, 2020
Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the LungKristin Baird, John Glod, Seth M Steinberg, et al.
Advanced Healthcare Materials|February 23, 2026
Detection of Extracellular Vesicles with Colocalized Surface Markers via a Capture-Release-Capture Strategy for Treatment Monitoring in Ewing SarcomaYou-Ren Ji, Yong Ju, Hui Kong, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 29, 2022
Coupling Lipid Labeling and Click Chemistry Enables Isolation of Extracellular Vesicles for Noninvasive Detection of Oncogenic Gene AlterationsNa Sun, Benjamin V Tran, Zishan Peng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2025
Erratum: Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal TumorsLeo Mascarenhas, Steven G DuBois, Catherine M Albert, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
The Lancet. Oncology|April 3, 2018
Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 studyTheodore W Laetsch, Steven G DuBois, Leo Mascarenhas, et al.
JCO Precision Oncology|January 8, 2019
Clinical Factors That Affect the Establishment of Soft Tissue Sarcoma Patient-Derived Orthotopic Xenografts: A University of California, Los Angeles, Sarcoma Program Prospective Clinical TrialTara A Russell, Mark A Eckardt, Takashi Murakami, et al.
American Journal of Clinical Oncology|April 18, 2018
Long-term Outcomes With Ifosfamide-based Hypofractionated Preoperative Chemoradiotherapy for Extremity Soft Tissue SarcomasJoseph Daniel Pennington, Fritz C Eilber, Frederick R Eilber, et al.
Oncotarget|June 11, 2016
Effective molecular targeting of CDK4/6 and IGF-1R in a rare FUS-ERG fusion CDKN2A-deletion doxorubicin-resistant Ewing's sarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse modelTakashi Murakami, Arun S Singh, Tasuku Kiyuna, et al.
Advanced Functional Materials|July 5, 2021
Coupling Nanostructured Microchips with Covalent Chemistry Enables Purification of Sarcoma-Derived Extracellular Vesicles for Downstream Functional StudiesJiantong Dong, Ryan Y Zhang, Na Sun, et al.
Surgery|October 10, 2025
Dedicated review of sarcoma pathology is necessary for corroborative diagnosis in nearly one half of referred patientsMark A Eckardt, Nicholas M Siena, Amy R Copeland, et al.
Sarcoma|May 14, 2020
Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the LungKristin Baird, John Glod, Seth M Steinberg, et al.
Advanced Healthcare Materials|February 23, 2026
Detection of Extracellular Vesicles with Colocalized Surface Markers via a Capture-Release-Capture Strategy for Treatment Monitoring in Ewing SarcomaYou-Ren Ji, Yong Ju, Hui Kong, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 29, 2022
Coupling Lipid Labeling and Click Chemistry Enables Isolation of Extracellular Vesicles for Noninvasive Detection of Oncogenic Gene AlterationsNa Sun, Benjamin V Tran, Zishan Peng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2025
Erratum: Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal TumorsLeo Mascarenhas, Steven G DuBois, Catherine M Albert, et al.
Pageof 12